Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder
Sign Up to like & getrecommendations! Published in 2020 at "Depression and Anxiety"
DOI: 10.1002/da.23029
Abstract: Cohort and cost‐effectiveness studies suggest that measuring variation in genes that influence metabolism of common drugs could improve antidepressant treatment outcomes. Prior randomized trials have yielded inconsistent results. read more here.
Keywords: blind trial; randomized controlled; participant rater; treatment ... See more keywords
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
Sign Up to like & getrecommendations! Published in 2018 at "Neurotherapeutics"
DOI: 10.1007/s13311-018-0620-9
Abstract: Oromandibular dystonia (OMD) causes involuntary movements of masticatory and lingual muscles impairing eating, speaking, and swallowing. Treatment options are limited. The objective of this study was to determine the safety and efficacy of abobotulinumtoxinA (aboBoNTA)… read more here.
Keywords: phase; blind trial; dystonia; oromandibular dystonia ... See more keywords